Fredun Pharmaceuticals Limited at its board meeting held on May 07, 2024 recommended Final Dividend at 7% per Equity Share having Face Value of INR 10/each for the Financial Year 2023-24; subject to the approval of the Shareholders at the upcoming 37th Annual General Meeting of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
923.6 INR | -2.38% | +0.59% | +6.31% |
05-10 | Fredun Pharmaceuticals Limited Proposes Final Dividend for the Financial Year 2023-24 | CI |
05-08 | Fredun Pharmaceuticals' Net Profit Jumps in Fiscal Q4; Shares Dip 9% | MT |
1st Jan change | Capi. | |
---|---|---|
+6.31% | 53.15M | |
+51.86% | 798B | |
+41.51% | 633B | |
-5.13% | 356B | |
+19.50% | 328B | |
+10.02% | 304B | |
+17.66% | 244B | |
+3.39% | 227B | |
+10.75% | 216B | |
+7.02% | 166B |
- Stock Market
- Equities
- FREDUN6 Stock
- News Fredun Pharmaceuticals Limited
- Fredun Pharmaceuticals Limited Proposes Final Dividend for the Financial Year 2023-24